These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25226384)

  • 1. Hibiscus sabdariffa polyphenols alleviate insulin resistance and renal epithelial to mesenchymal transition: a novel action mechanism mediated by type 4 dipeptidyl peptidase.
    Peng CH; Yang YS; Chan KC; Wang CJ; Chen ML; Huang CN
    J Agric Food Chem; 2014 Oct; 62(40):9736-43. PubMed ID: 25226384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hibiscus sabdariffa polyphenols prevent palmitate-induced renal epithelial mesenchymal transition by alleviating dipeptidyl peptidase-4-mediated insulin resistance.
    Huang CN; Wang CJ; Yang YS; Lin CL; Peng CH
    Food Funct; 2016 Jan; 7(1):475-82. PubMed ID: 26514092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyphenols of Hibiscus sabdariffa improved diabetic nephropathy via attenuating renal epithelial mesenchymal transition.
    Yang YS; Wang CJ; Huang CN; Chen ML; Chen MJ; Peng CH
    J Agric Food Chem; 2013 Aug; 61(31):7545-51. PubMed ID: 23848500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dipeptidyl peptidase-4 inhibitor linagliptin attenuates inflammation and accelerates epithelialization in wounds of diabetic ob/ob mice.
    Schürmann C; Linke A; Engelmann-Pilger K; Steinmetz C; Mark M; Pfeilschifter J; Klein T; Frank S
    J Pharmacol Exp Ther; 2012 Jul; 342(1):71-80. PubMed ID: 22493041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen.
    Kanasaki K; Shi S; Kanasaki M; He J; Nagai T; Nakamura Y; Ishigaki Y; Kitada M; Srivastava SP; Koya D
    Diabetes; 2014 Jun; 63(6):2120-31. PubMed ID: 24574044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyphenol extracts from Hibiscus sabdariffa Linnaeus attenuate nephropathy in experimental type 1 diabetes.
    Lee WC; Wang CJ; Chen YH; Hsu JD; Cheng SY; Chen HC; Lee HJ
    J Agric Food Chem; 2009 Mar; 57(6):2206-10. PubMed ID: 19219995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hibiscus sabdariffa polyphenolic extract inhibits hyperglycemia, hyperlipidemia, and glycation-oxidative stress while improving insulin resistance.
    Peng CH; Chyau CC; Chan KC; Chan TH; Wang CJ; Huang CN
    J Agric Food Chem; 2011 Sep; 59(18):9901-9. PubMed ID: 21870884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomy.
    Tsuprykov O; Ando R; Reichetzeder C; von Websky K; Antonenko V; Sharkovska Y; Chaykovska L; Rahnenführer J; Hasan AA; Tammen H; Alter M; Klein T; Ueda S; Yamagishi SI; Okuda S; Hocher B
    Kidney Int; 2016 May; 89(5):1049-1061. PubMed ID: 27083282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition.
    Shi S; Srivastava SP; Kanasaki M; He J; Kitada M; Nagai T; Nitta K; Takagi S; Kanasaki K; Koya D
    Kidney Int; 2015 Sep; 88(3):479-89. PubMed ID: 25830763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linagliptin enhances neural stem cell proliferation after stroke in type 2 diabetic mice.
    Darsalia V; Olverling A; Larsson M; Mansouri S; Nathanson D; Nyström T; Klein T; Sjöholm Å; Patrone C
    Regul Pept; 2014 May; 190-191():25-31. PubMed ID: 24821550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
    Kodera R; Shikata K; Takatsuka T; Oda K; Miyamoto S; Kajitani N; Hirota D; Ono T; Usui HK; Makino H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):828-33. PubMed ID: 24342619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hibiscus sabdariffa (roselle) polyphenol-rich extract averts cardiac functional and structural abnormalities in type 1 diabetic rats.
    Mohammed Yusof NL; Zainalabidin S; Mohd Fauzi N; Budin SB
    Appl Physiol Nutr Metab; 2018 Dec; 43(12):1224-1232. PubMed ID: 29726706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linagliptin blocks renal damage in type 1 diabetic rats by suppressing advanced glycation end products-receptor axis.
    Nakashima S; Matsui T; Takeuchi M; Yamagishi SI
    Horm Metab Res; 2014 Sep; 46(10):717-21. PubMed ID: 24710699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin.
    Kanasaki K
    Clin Sci (Lond); 2018 Feb; 132(4):489-507. PubMed ID: 29491123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abelmoschus esculentus subfractions improved nephropathy with regulating dipeptidyl peptidase-4 and type 1 glucagon-like peptide receptor in type 2 diabetic rats.
    Peng CH; Lin HC; Lin CL; Wang CJ; Huang CN
    J Food Drug Anal; 2019 Jan; 27(1):135-144. PubMed ID: 30648566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linagliptin but not Sitagliptin inhibited transforming growth factor-β2-induced endothelial DPP-4 activity and the endothelial-mesenchymal transition.
    Shi S; Kanasaki K; Koya D
    Biochem Biophys Res Commun; 2016 Feb; 471(1):184-90. PubMed ID: 26826382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding to dipeptidyl peptidase-4 determines the disposition of linagliptin (BI 1356)--investigations in DPP-4 deficient and wildtype rats.
    Retlich S; Withopf B; Greischel A; Staab A; Jaehde U; Fuchs H
    Biopharm Drug Dispos; 2009 Nov; 30(8):422-36. PubMed ID: 19771584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors.
    Thomas L; Eckhardt M; Langkopf E; Tadayyon M; Himmelsbach F; Mark M
    J Pharmacol Exp Ther; 2008 Apr; 325(1):175-82. PubMed ID: 18223196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats.
    Uchii M; Kimoto N; Sakai M; Kitayama T; Kunori S
    Eur J Pharmacol; 2016 Jul; 783():56-63. PubMed ID: 27063445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipeptidyl peptidase-4 plays a pathogenic role in BSA-induced kidney injury in diabetic mice.
    Takagaki Y; Shi S; Katoh M; Kitada M; Kanasaki K; Koya D
    Sci Rep; 2019 May; 9(1):7519. PubMed ID: 31101909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.